Related Experiment Video
Updated: Apr 27, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ
Gerard London1, Adrian Covic2, David Goldsmith3
1INSERM U970, Hôpital Européen Georges Pompidou , Paris, France.
Insights
Patients with chronic kidney disease (CKD) experience accelerated arterial aging, leading to cardiovascular disease. Understanding the causes of this premature aging is crucial for improving patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Gerontology
Background:
- Cardiovascular disease (CVD) significantly contributes to morbidity and mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- Epidemiological studies consistently demonstrate accelerated arterial and cardiac aging in CKD/ESRD populations.
- Premature arterial aging in these patients is characterized by aortic stiffening and loss of central-peripheral stiffness gradients.
Approach:
- This review synthesizes current understanding of arterial and cardiac aging in CKD/ESRD.
- It examines the heterogeneous nature of premature arterial aging, focusing on central arteries.
- The impact of these vascular changes on cardiac and microcirculatory function is discussed.
Key Points:
- Accelerated arterial aging, particularly aortic stiffening, is a hallmark of CKD/ESRD.
- Vascular aging impacts the heart (left ventricular hypertrophy, reduced coronary perfusion) and microcirculation (renal and brain).
- The pathophysiology of aortic 'progeria' and associated microvascular disorders in CKD/ESRD remains incompletely understood.
Conclusions:
- Accelerated aging of the aorta and central arteries is a critical factor in cardiovascular complications of CKD/ESRD.
- Further research into the multifactorial pathophysiology of vascular aging in CKD/ESRD is warranted.
- Understanding these mechanisms is essential for developing targeted interventions to mitigate cardiovascular risk in these patients.
Abstract:
Cardiovascular disease is an important cause of morbidity and mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). All epidemiological studies have clearly shown that accelerated arterial and cardiac aging is characteristic of these populations. Arterial premature aging is heterogeneous. It principally involves the aorta and central capacitive arteries, and is characterized by preferential aortic stiffening and disappearance of stiffness/impedance gradients between the central and peripheral arteries. These changes have a double impact: on the heart, upstream, with left ventricular hypertrophy and decreased coronary perfusion; and, downstream, on renal and brain microcirculation (decrease in glomerular filtration and cognitive functions). Multifactorial at origin, the pathophysiology of aortic 'progeria' and microvascular disorders in CKD/ESRD is not well understood and should be the focus of interest in future studies.
Related Concept Videos
Pathophysiology of Heart Failure
Chronic Kidney Disease I: Introduction
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease IV: Nursing Management
Hypertension II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations

